BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11906745)

  • 21. Alzheimer's disease: clues from flies and worms.
    Anderton BH
    Curr Biol; 1999 Feb; 9(3):R106-9. PubMed ID: 10021378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C. elegans as a model system to accelerate discovery for Parkinson disease.
    Martinez BA; Caldwell KA; Caldwell GA
    Curr Opin Genet Dev; 2017 Jun; 44():102-109. PubMed ID: 28242493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.
    Giacomotto J; Pertl C; Borrel C; Walter MC; Bulst S; Johnsen B; Baillie DL; Lochmüller H; Thirion C; Ségalat L
    Hum Mol Genet; 2009 Nov; 18(21):4089-101. PubMed ID: 19648295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burrowing behavior of the nematode Caenorhabditis elegans: a new assay for the study of neuromuscular disorders.
    Beron C; Vidal-Gadea AG; Cohn J; Parikh A; Hwang G; Pierce-Shimomura JT
    Genes Brain Behav; 2015 Apr; 14(4):357-68. PubMed ID: 25868909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dying for a cause: invertebrate genetics takes on human neurodegeneration.
    Driscoll M; Gerstbrein B
    Nat Rev Genet; 2003 Mar; 4(3):181-94. PubMed ID: 12610523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.
    Vistbakka J; VanDuyn N; Wong G; Nass R
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):957-64. PubMed ID: 23244419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invertebrate models of lamin diseases.
    Rzepecki R; Gruenbaum Y
    Nucleus; 2018 Jan; 9(1):227-234. PubMed ID: 29557730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-developmentally programmed cell death in Caenorhabditis elegans.
    Kourtis N; Tavernarakis N
    Semin Cancer Biol; 2007 Apr; 17(2):122-33. PubMed ID: 17196824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans.
    Gieseler K; Mariol MC; Bessou C; Migaud M; Franks CJ; Holden-Dye L; Ségalat L
    J Mol Biol; 2001 Mar; 307(1):107-17. PubMed ID: 11243807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence and expression of the kettin gene in Drosophila melanogaster and Caenorhabditis elegans.
    Kolmerer B; Clayton J; Benes V; Allen T; Ferguson C; Leonard K; Weber U; Knekt M; Ansorge W; Labeit S; Bullard B
    J Mol Biol; 2000 Feb; 296(2):435-48. PubMed ID: 10669599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
    Tucci ML; Harrington AJ; Caldwell GA; Caldwell KA
    Methods Mol Biol; 2011; 793():129-48. PubMed ID: 21913098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caenorhabditis elegans Gets Metabolic Network Models.
    Taubert S
    Cell Syst; 2016 May; 2(5):293-4. PubMed ID: 27228345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caenorhabditis elegans as a model to study renal development and disease: sexy cilia.
    Barr MM
    J Am Soc Nephrol; 2005 Feb; 16(2):305-12. PubMed ID: 15647338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Li J; Cui X; Ma X; Wang Z
    Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans.
    Nyamsuren O; Faggionato D; Loch W; Schulze E; Baumeister R
    Dev Biol; 2007 Dec; 312(1):193-202. PubMed ID: 17961535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models of Alzheimer's disease embrace diversity.
    Neff EP
    Lab Anim (NY); 2019 Sep; 48(9):255-259. PubMed ID: 31435040
    [No Abstract]   [Full Text] [Related]  

  • 40. Invertebrate models of Alzheimer's disease.
    Mhatre SD; Paddock BE; Saunders AJ; Marenda DR
    J Alzheimers Dis; 2013; 33(1):3-16. PubMed ID: 22886023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.